Drugs Rules, 1945 amended: applicants who submit fake or fabricated data can be debarred from filing further applications
The Union Health Ministry says it has notified amendments to the Drugs Rules, 1945 that empower the Licensing Authority to debar entities submitting fake or fabricated data from filing further applications for a specified period. A show-cause notice must be issued first, and an appeal is provided.
Key facts
- In force
- Not stated in the release
- Who it affects
- Drug manufacturers, importers, distributors and every other applicant filing applications under the Drugs Rules, 1945 before State or Central licensing authorities
- What it is
- Rule change
- Section
- Licences
- Published
- 6 August 2026
In 30 seconds
- The release cites the notification as “G.S.R number 756 (E), dated the 16th October, 2025”.
- The Licensing Authority is empowered to debar further applications by entities who submit fake or fabricated data in support of their applications.
- This applies to all applications filed under various provisions of the Drugs Rules, 1945.
- The debarment is from filing further applications with the concerned regulatory authority — State or Centre, as applicable — for a specified period of time.
- A show-cause notice has to be issued before any such action, and there is a provision for appeal.
- The new power is in addition to the existing enforcement provisions under the Drugs and Cosmetics Act, 1940.
हिंदी में सार
स्वास्थ्य मंत्रालय के अनुसार Drugs Rules, 1945 में संशोधन अधिसूचित किया गया है (रिलीज़ में संदर्भ: G.S.R. 756 (E), 16 अक्टूबर 2025)। अब जो आवेदक अपने आवेदन के साथ फ़र्ज़ी या गढ़ा हुआ डेटा देगा, उसे Licensing Authority एक तय अवधि के लिए आगे आवेदन करने से रोक (debar) सकती है। कार्रवाई से पहले कारण बताओ नोटिस देना ज़रूरी है और अपील का प्रावधान भी है। अवधि कितनी होगी, यह रिलीज़ में नहीं बताया गया है।
Before and now
Enforcement actions such as rejection of the application and/or cancellation of existing licences.
In addition, debarment from filing further applications with the concerned State or Central authority for a specified period, after a show-cause notice and with a right of appeal.
What has been notified
In a release dated 6 August 2026, the Union Ministry of Health and Family Welfare says it has notified amendments to the Drugs Rules, 1945 “through G.S.R number 756 (E), dated the 16th October, 2025”. The reference is reproduced here exactly as the release prints it.
According to the release, the newly notified provisions empower the Licensing Authority to debar further applications by entities who submit fake or fabricated data in support of their applications. The Ministry says this will apply to all applications filed under various provisions of the Drugs Rules, 1945, and that it is in addition to the existing enforcement provisions under the Drugs and Cosmetics Act, 1940.
What changes for an applicant
| Point | What the release says |
|---|---|
| Position so far | An applicant submitting fabricated data faces enforcement actions such as rejection of applications and/or cancellation of existing licences |
| Added by the amendment | Debarment from filing further applications with the concerned regulatory authority, either State or the Centre (as applicable) |
| Duration | “A specified period of time” — the release does not say how long |
| Due process | A show-cause notice is to be issued before any such punitive action is taken |
| Remedy | A provision for appeal is provided |
Why the Ministry says it is needed
The release explains that scientific data submitted by applicants is the basis on which the regulator evaluates the quality, safety and efficacy of drugs. Submission of fake or fabricated data, it says, compromises the integrity of the regulatory process and may pose serious risks to public health. The amendment is intended to deter such misconduct, strengthen accountability among applicants and ensure that drug approvals are backed by reliable and scientifically valid evidence.
The Ministry adds that the notification is in line with its efforts to strengthen the regulatory framework in accordance with global best practices, and that it aims to promote manufacturers and distributors who comply with that framework.
What the release leaves out
The release does not give the rule numbers that have been amended, the length of the debarment, the authority that hears the appeal or the time allowed for it, or the date from which the provisions apply. It says the complete text of the G.S.R. is available on the e-Gazette and gives a link to it.
What applicants should do
Manufacturers, importers and others who file applications under the Drugs Rules, 1945 should read the notification from the e-Gazette link in the release and make sure that the data filed in support of every application can be verified. If a show-cause notice is received, it has to be answered; the release says an appeal is available against the action taken.
Questions and answers
What happens if an applicant submits fake or fabricated data under the Drugs Rules, 1945?
According to the Health Ministry’s release, besides the existing actions such as rejection of the application and/or cancellation of existing licences, the Licensing Authority can now debar the applicant from filing further applications with the concerned State or Central authority for a specified period.
Is the applicant heard before being debarred?
Yes. The release says a due process has been prescribed through the issuance of a show-cause notice before any such punitive action, and that there is also a provision for appeal.
Which notification makes the change?
The release cites it as “G.S.R number 756 (E), dated the 16th October, 2025” and links the text on the e-Gazette.
For how long can an applicant be debarred?
The release says only “for a specified period of time”. The period is not given in the release; the text of the notification has to be read for it.
Published 6 August 2026. Updated 7 October 2026. This report is for general information and is not professional advice. Read the source document before acting on it.